We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRS icon
526
Northern Trust
NTRS
$22.4B
$316K 0.01%
4,765
-12,770
-73% -$889K
CNQ icon
527
Canadian Natural Resources
CNQ
$99.3B
$311K 0.01%
20,616
-268
-1% -$3.79K
MACK
528
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$311K 0.01%
+7,329
New +$399K
MNST icon
529
Monster Beverage
MNST
$94.3B
$309K 0.01%
11,526
-888
-7% -$21.4K
HPQ icon
530
HP
HPQ
$24.7B
$307K 0.01%
24,489
-8,800
-26% -$110K
VB icon
531
Vanguard Morningstar Small-Cap ETF
VB
$79.3B
$304K 0.01%
2,630
-100
-4% -$11.4K
BNCL
532
DELISTED
Beneficial Bancorp, Inc.
BNCL
$304K 0.01%
23,865
+275
+1% +$3.73K
RAI
533
DELISTED
Reynolds American Inc
RAI
$303K 0.01%
5,625
-86
-2% -$4.32K
XHB icon
534
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
$300K 0.01%
8,936
+195
+2% +$6.59K
MFG icon
535
Mizuho Financial
MFG
$126B
$299K 0.01%
104,998
CNS icon
536
Cohen & Steers
CNS
$4.19B
$297K 0.01%
+7,350
New +$289K
YUM icon
537
Yum! Brands
YUM
$42.5B
$294K 0.01%
4,926
-449
-8% -$26.5K
AET
538
DELISTED
Aetna Inc
AET
$294K 0.01%
+2,406
New +$276K
FLOT icon
539
iShares Floating Rate Bond ETF
FLOT
$10.2B
$293K 0.01%
5,779
-331
-5% -$16.7K
PFF icon
540
iShares Preferred and Income Securities ETF
PFF
$13.2B
$290K 0.01%
+7,280
New +$285K
NXPI icon
541
NXP Semiconductors
NXPI
$62B
$285K 0.01%
3,640
UN
542
DELISTED
Unilever NV New York Registry Shares
UN
$282K 0.01%
6,000
-800
-12% -$35.8K
CHTR icon
543
Charter Communications
CHTR
$17.2B
$280K 0.01%
+1,226
New +$263K
GBF icon
544
iShares Government/Credit Bond ETF
GBF
$133M
$277K 0.01%
2,350
-375
-14% -$43.3K
SWBI icon
545
Smith & Wesson
SWBI
$653M
$277K 0.01%
13,270
-1,561
-11% -$27.9K
THO icon
546
Thor Industries
THO
$3.87B
$269K 0.01%
+4,157
New +$266K
ITG
547
DELISTED
Investment Technology Group Inc
ITG
$268K 0.01%
16,040
+80
+0.5% +$1.5K
RIO icon
548
Rio Tinto
RIO
$158B
$266K 0.01%
8,490
ZBH icon
549
Zimmer Biomet
ZBH
$17.8B
$266K 0.01%
2,273
-907
-29% -$103K
CERN
550
DELISTED
Cerner Corp
CERN
$264K 0.01%
4,500
-1,020
-18% -$56.8K

Similar funds

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.